Abstract
Archived formalin-fixed, paraffin embedded (FFPE) tissues constitute a vast, well-annotated, but underexploited resource for the molecular study of cancer progression, largely because degradation, chemical modification, and cross-linking, render FFPE RNA a suboptimal substrate for conventional analytical methods. We report here a modified protocol for RNA extraction from FFPE tissues which maximized the success rate (with 100% of samples) in the expression profiling of a set of 60 breast cancer samples on the WG-DASL platform; yielding data of sufficient quality such that in hierarchical clustering (a) 12/12 (100%) replicates correctly identified their respective counterparts, with a high self-correlation (r = 0.979), and (b) the overall sample set grouped with high specificity into ER+ (38/40; 95%) and ER− (18/20; 90%) subtypes. These results indicate that a large fraction of decade-old FFPE samples, of diverse institutional origins and processing histories, can yield RNA suitable for gene expression profiling experiments.


Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Abramovitz M, Ordanic-Kodani M, Wang Y, Li Z, Catzavelos C, Bouzyk M, Sledge GW Jr, Moreno CS, Leyland-Jones B (2008) Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay. BioTechniques 44:417–423
April C, Klotzle B, Royce T, Wickham-Garcia E, Boyaniwsky T, Izzo J, Cox D, Jones W, Rubio R, Holton K, Matulonis U, Quackenbush J, Fan JB (2009) Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. PLoS One 4:e8162
Bibikova M, Talantov D, Chudin E, Yeakley JM, Chen J, Doucet D, Wickham E, Atkins D, Barker D, Chee M, Wang Y, Fan JB (2004) Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol 165:1799–1807
Bibikova M, Yeakley JM, Chudin E, Chen J, Wickham E, Wang-Rodriguez J, Fan JB (2004) Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis. Clin Chem 50:2384–2386
Bibikova M, Chudin E, Arsanjani A, Zhou L, Garcia EW, Modder J, Kostelec M, Barker D, Downs T, Fan JB, Wang-Rodriguez J (2007) Expression signatures that correlated with Gleason score and relapse in prostate cancer. Genomics 89:666–672
Bouchie A (2004) Coming soon: a global grid for cancer research. Nat Biotechnol 22:1071–1073
Burr TD R, Green A, Ellis I, Murray C (2008) Evaluating gene expression in FFPE tissues using DASL: validation by quantitative real-time PCR and immunohistochemistry. National Cancer Research Institute conference poster B31
Du P, Kibbe WA, Lin SM (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24:1547–1548
Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van’t Veer LJ, Perou CM (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560–569
Grübel R (1988) The length of the Shorth. Ann Stat 16:9
Haller AC, Kanakapalli D, Walter R, Alhasan S, Eliason JF, Everson RB (2006) Transcriptional profiling of degraded RNA in cryopreserved and fixed tissue samples obtained at autopsy. BMC Clin Pathol 6:9
Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359:1995–2004
Hu Z, Fan C, Oh D, Hu Z, Fan C, Oh D, Marrow J, He X, Qaqish B, Livasy C, Carey L, Reynolds E, Dressler L, Nobel A, Parker J, Ewend M, Sawyer L, Wu J, Liu Y, Nanda R, Tretiakova M, Orrico A, Dreher D, Palazzo J, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush J, Ellis M, Olopade O, Bernard P, Perou C (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96
Li HR, Wang-Rodriguez J, Nair TM, Yeakley JM, Kwon YS, Bibikova M, Zheng C, Zhou L, Zhang K, Downs T, Fu XD, Fan JB (2006) Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens. Cancer Res 66:4079–4088
Linton K, Hey Y, Dibben S, Miller C, Freemont A, Radford J, Pepper S (2009) Methods comparison for high-resolution transcriptional analysis of archival material on Affymetrix Plus 2.0 and Exon 1.0 microarrays. BioTechniques 47:587–596
Paik S (2006) Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy. Clin Cancer Res 12:1019s–1023s
Penland SK, Keku TO, Torrice C, He X, Krishnamurthy J, Hoadley KA, Woosley JT, Thomas NE, Perou CM, Sandler RS, Sharpless NE (2007) RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Invest 87:383–391
Perou C, Serlie T, Eisen M, van de Rijins M, Jeffrey S, Rees C, Pollack J, Ross D, Johnsen H, Akslen L, Fluge O, Pergamenschikov A, Williams C, Zhu S, Lenning P, Borresen-Dale A, Brown P, Botstein D (2000) Molecular portraits of human breast tumors. Nature 406:747–752
Ravo M, Mutarelli M, Ferraro L, Grober OM, Paris O, Tarallo R, Vigilante A, Cimino D, De Bortoli M, Nola E, Cicatiello L, Weisz A (2008) Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. Lab Invest 88:430–440
Sorlie T, Perou C, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen M, van de Rijn M, Jeffrey S, Thorsen T, Quist H, Matese J, Brown P, Botstein D, Eystein Lonning P, Borresen-Dale A (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874
Reding KWD, DR, McTiernan A, Hsu L, Davis S, Daling JR, Porter PL, Malone KE (submitted) Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer. Breast Cancer Research Treatment
Acknowledgments
This study was supported by funding: NIH/NCI R01CA098858 (KEM, CIL, PLP, LH); Safeway Foundation (PLP, KEM); NIH/NCI P50 CA148143 (PLP). The authors wish to thank Ryan Basom for assistance with use of Bioconductor lumi package, and in data preprocessing.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ton, C.C., Vartanian, N., Chai, X. et al. Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL® sample preparation. Breast Cancer Res Treat 125, 879–883 (2011). https://doi.org/10.1007/s10549-010-1159-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-010-1159-6